PlainRecalls
FDA Drug Moderate Class II Terminated

Allergy, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 72288-847-39), and b)150-count cartons (NDC 72288-847-47 and 72288-847-37), Distributed By: Amazon.com Services LLC., 410 Terry Avenue N., Seattle, WA 98109.

Reported: July 19, 2023 Initiated: February 9, 2023 #D-0900-2023

Product Description

Allergy, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 72288-847-39), and b)150-count cartons (NDC 72288-847-47 and 72288-847-37), Distributed By: Amazon.com Services LLC., 410 Terry Avenue N., Seattle, WA 98109.

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Recalling Firm
L. Perrigo Company
Units Affected
11,904 cartons
Distribution
Nationwide within the USA
Location
Allegan, MI

Frequently Asked Questions

What product was recalled?
Allergy, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 72288-847-39), and b)150-count cartons (NDC 72288-847-47 and 72288-847-37), Distributed By: Amazon.com Services LLC., 410 Terry Avenue N., Seattle, WA 98109.. Recalled by L. Perrigo Company. Units affected: 11,904 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on July 19, 2023. Severity: Moderate. Recall number: D-0900-2023.